Immunotherapy of HIV-seropositive patients: preliminary report on a dose-ranging study

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1329-31. doi: 10.1089/aid.1992.8.1329.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Randomized Controlled Trial

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / immunology
  • AIDS Vaccines / therapeutic use*
  • CD4-Positive T-Lymphocytes
  • Dose-Response Relationship, Immunologic
  • Double-Blind Method
  • Freund's Adjuvant
  • HIV Antibodies / blood
  • HIV Core Protein p24 / immunology
  • HIV Seropositivity / immunology
  • HIV Seropositivity / therapy*
  • Humans
  • Hypersensitivity, Delayed / immunology
  • Immunity, Cellular
  • Immunotherapy, Active*
  • Leukocyte Count
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / immunology
  • Vaccines, Inactivated / therapeutic use

Substances

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Core Protein p24
  • Vaccines, Inactivated
  • Freund's Adjuvant